Effect of Cell Autophagy on the Apoptosis of Hepatocellular Carcinoma Cells Induced by Arsenic Trioxide

LI Yang, GU Shi-yan, ZHANG Zun-zhen

Abstract

To determine the effect of autophagy on the apoptosis of hepatocellular carcinoma cells induced by arsenic trioxide (ATO). Methods Hepatocellular carcinoma HepG2 cells were exposed to ATO. The cell viability was detected by MTT after adjustments for autophagy agonist (Rap) and autophagy inhibitor (3-MA). The autophagosome was observed under electronic microscope. The autophagy related proteins (LC3 and Beclin1) were detected by immunofluorescence. The cell apoptosis was measured by flow cytometry. Results With 5-20 μmol/Lof ATO, HepG2 cells exposed to 3-MA had significantly lower viability (P <0.05) and higher early apoptosis (P <0.05) than those without exposure to 3-MA. Exposure to 3-MA was also associated with lower expressions of LC3 and Beclin1, with HepG2 cells showing typical apoptotic characteristics. By contrast, with 5-20 μmol/Lof ATO, the cells exposed to Rap showed significantly higher viability (P <0.05) and lower early apoptosis (P <0.05) than those without exposure to Rap. A large number of autophagosome appeared in the cells exposed to Rap. Exposure to Rap was associated with increased expressions of LC3 and Beclin1, but with no statistical significance (P >0.05). Conclusion Targeted autophagy inhibition can significantly increase the sensitivity of HepG2 to ATO. The underlining mechanism is associated with enhanced apoptosis of hepatocellular carcinoma cells.

 

Keywords: Hepatocellular carcinoma, Arsenic trioxide, Autophagy, Apoptosis 

 

Full Text:

PDF


References


MIZUSHIMA N, YOSHIMORI T, LEVINE B. Methods in mammalian autophagy research. Cell,2010,140(3) :313-326. KLIONSKY DJ, SALTIEL AR. Autophagy works out. Cell Metab ,2012,15(3): 273-274.

PAN Y, GAO Y, CHEN L, et al. Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA- damaging chemotherapy. Clin Cancer Res, 2011, 17 ( 10): 3248-3258.

CHEN GQ, SHI XG, TANG W. et al. Use of arsenic trioxide ( AS2O3 ) in the treatment of acute promyelocytic leukemia (APL). I. AS2O3 exerts dose-dependent dual effects on APL cells. Blood, 1997,89(9) ;3345-3353.

LIN LM, LI ВХ, XIАО JB, et al. Synergistic effect of all- trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro. World J Gastroenterol, 2005, 11 ( 36); 5633-5637.

LUO Q. LI Y, LAI Y, et al. The role of NF-kappaB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells. J Toxicol Sci,2015,40(3) :349-363.

WHITE E. Deconvolving the context-dependent role for autophagy in cancer. Nat Rev Cancer,2012,12(6) : 401-410. EDINGER AL, THOMPSON CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol. 2004,16(6)j 663-669.

RUBINSTEIN AD, KIMCHI A. Life in the balance a mechanistic view of the crosstalk between autophagy and apoptosis. J Cell Sci,2012,125(Pt 22);5259-5268.

XUE L, FLETCHER GC, TOLKOVSKY AM. Autophagy is activated by apoptotic signalling in sympathetic neurons; an alternative mechanism of death execution. Mol Cell Neurosci, 1999,14(3)j180-198.

MARINO G, NISO-SANTANO M, BAEHRECKE EH, et al. Self-consumption; the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol,2014,15(2);81-94.

AUVYC, GANE P, ARICO S, et al. Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29. Exp Cell Res, 2001, 268 ( 2 ) ; 139-149.

CHEN S, REHMAN S K, ZHANG W, et al. Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta, 2010,1806(2): 220-229.


Refbacks

  • There are currently no refbacks.